AMCPX
Price
$44.17
Change
-$0.07 (-0.16%)
Updated
Sep 20 closing price
GFACX
Price
$66.58
Change
-$0.13 (-0.19%)
Updated
Sep 20 closing price
Ad is loading...

AMCPX vs GFACX

Header iconAMCPX vs GFACX Comparison
Open Charts AMCPX vs GFACXBanner chart's image
American Funds AMCAP A
Price$44.17
Change-$0.07 (-0.16%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer C
Price$66.58
Change-$0.13 (-0.19%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
AMCPX vs GFACX Comparison Chart
Loading...
VS
AMCPX vs. GFACX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMCPX is a Buy and GFACX is a StrongBuy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 290B vs. AMCPX (89.3B). AMCPX pays higher dividends than GFACX: AMCPX (0.50) vs GFACX (0.00). AMCPX was incepted earlier than GFACX: AMCPX (57 years) vs GFACX (24 years). AMCPX (31.00) and GFACX (31.00) have comparable annual turnover. AMCPX (250) and GFACX (250) have matching initial minimum investment requirements. AMCPX (28.67) and GFACX (28.04) have marching annual gain over last year. GFACX return over 5 years is better than : 45.21 vs. AMCPX (38.72).
AMCPXGFACXAMCPX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence57 years24 years-
Gain YTD15.87121.05575%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets89.3B290B31%
Annual Yield % from dividends0.500.00-
Returns for 1 year28.6728.04102%
Returns for 3 years0.70-3.58-20%
Returns for 5 years38.7245.2186%
Returns for 10 years54.6252.57104%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BTDR7.110.31
+4.63%
Bitdeer Technologies Group
ESCA13.800.15
+1.10%
Escalade
GDDY160.550.41
+0.26%
GoDaddy
CCOI72.32-0.09
-0.12%
Cogent Communications Holdings
CANF1.98-0.04
-1.98%
Can-Fite BioPharma Ltd